Skip to main content
SpringerLink
Log in

ASO Author Reflections: Omitting Radiotherapy for Ductal Carcinoma In Situ Patients with Lumpectomy: Now or in the Future?

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Wapnir IL, Dignam JJ, Fisher B, et al. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst. 2011; 103(6): 478–88.

    Article  Google Scholar 

  2. Fisher B, Dignam J, Wolmark N, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol. 1998; 16(2): 441–52.

    Article  CAS  Google Scholar 

  3. Solin LJ, Gray R, Hughes LL, et al. Surgical excision without radiation for ductal carcinoma in situ of the breast: 12-year results from the ECOG-ACRIN E5194 study. J Clin Oncol. 2015; 33(33): 3938–44.

    Article  Google Scholar 

  4. Yang L, Lu D, Lai Y, et al. Prognostic score based stratification analysis reveals universal benefits of radiotherapy on lowering the risk of ipsilateral breast event for ductal carcinoma in situ patients with different risk levels. Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-09003-6.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Sagara Y, Freedman RA, Vaz-Luis I, et al. Patient prognostic score and associations with survival improvement offered by radiotherapy after breast-conserving surgery for ductal carcinoma in situ: a population-based longitudinal cohort study. J Clin Oncol. 2016; 34(11): 1190–6.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by the 1.3.5 project for disciplines of excellence (ZYGD18012).

Author information

Authors and Affiliations

  1. Department of Pathology, West China Hospital, Sichuan University, Chengdu, China

    Libo Yang MD, PhD & Hong Bu MD, PhD

  2. Laboratory of Pathology, West China Hospital, Sichuan University, Chengdu, China

    Libo Yang MD, PhD & Hong Bu MD, PhD

  3. Key Laboratory of Transplant Engineering and Immunology, Ministry of Health, West China Hospital, Sichuan University, Chengdu, China

    Libo Yang MD, PhD & Hong Bu MD, PhD

  4. Department of Life Sciences, Imperial College London, London, UK

    Dongli Lu PhD

Authors
  1. Libo Yang MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dongli Lu PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hong Bu MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hong Bu MD, PhD.

Ethics declarations

Disclosures

Libo Yang, Dongli Lu, and Hong Bu have no potential conflicts of interest to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yang, L., Lu, D. & Bu, H. ASO Author Reflections: Omitting Radiotherapy for Ductal Carcinoma In Situ Patients with Lumpectomy: Now or in the Future?. Ann Surg Oncol 27 (Suppl 3), 891–892 (2020). https://doi.org/10.1245/s10434-020-09035-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-020-09035-y

Search

Navigation